CN1068573A - Preparation phosphino-hydrocarbon-group VIII-metal complexes and contain the anti-tumor compositions method of these complex compounds - Google Patents
Preparation phosphino-hydrocarbon-group VIII-metal complexes and contain the anti-tumor compositions method of these complex compounds Download PDFInfo
- Publication number
- CN1068573A CN1068573A CN 92104055 CN92104055A CN1068573A CN 1068573 A CN1068573 A CN 1068573A CN 92104055 CN92104055 CN 92104055 CN 92104055 A CN92104055 A CN 92104055A CN 1068573 A CN1068573 A CN 1068573A
- Authority
- CN
- China
- Prior art keywords
- ethane
- weight
- iii
- perchlorate
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The present invention relates to prepare the method for following formula compound, wherein, D=phosphine, negatively charged ion are the trifluoromethane sulfonic acid root, M=Rh (I), and this method describes in detail sees specification sheets.
Description
The invention relates to new two (two (diphenylphosphino) alkyl) and two (diphenylphosphino-hexichol arsyl) alkyl) VIII family metallic compound.These metallic compounds have the inhibition tumor cell growth activity, contain the new pharmaceutical composition of these compounds that suppress tumor growth quantity and dye these compounds that the rout that tumour cell is arranged takes the antitumor cell increment and seek the method for tumour cell to these compound sensitivities by giving.
Eight group 4 transition metal complex compounds, particularly dichloride diamino platinum and it are used for the treatment of the several types cancer, and just the use of testis and ovarian cancer is described in the book below:
-M.J.Clare and P.C Hydes，Metal Ions in Biological Systems，Vol.11
-H.Sigel Edit，Marcel Dckker，New York（1980），1-62 and-S.Haghighi and C.A.Mc Auliffe.Rev.Inorg.Chem，3，291-351（1981）。
To having done further research along the relevant metal ammonia complex of dichloride phenodiazine platinum.Composition above-mentioned does not demonstrate activity or compares with active platinic compound and demonstrates than low activity in several antitumor pilot systems on mouse.
The metal complex of nonnitrogenous dentate system is seldom studied, except the phosphino-one alkyl IB family metal complex beyond the region of objective existence of mentioning later, metal complex in this gang does not show tangible anti-tumor activity (S, Haghighi and C.A.Mc Auliffe, Rev.Inorg, Chem.3,219-351(1981).
Still be starved of at present the chemical therapeutic method of treatment cancer.
Anti-some tumour of Chemo-Therapy therapy reply of the above-mentioned type demonstrates the tumour of high reactivity or antagonism wide spectrum and shows activity.The more important thing is the ability that such compound has the blocking-up resistance to exist for the antitumor chemotherapy that exists.
The present pharmaceutical active compounds of discoverable type 1, wherein: D
1=D
2=phosphine or D
2=arsenic, D
1=phosphorus
A=(CH
2)
2, (CH
2)
3Or suitable-CH=CH;
X
1=X
2(if the two all exists)=fontanel base or nitroxyl or
X
1+ X
2=peroxidation base.
Y(is as existing)=fontanelle compound, nitrate, perchlorate, triflate or four fontanels are for ferrate (III)
N=0,1 or 2;
The M=Fe(II), the Fe(III), the Co(II) and, the Rh(I), the Rh(III) and, the Ir(I), the Ir(III) and, the Ni(II) and the Pd(II).
Said nitrogen-atoms free metal complex has shown important anti-tumor activity.They demonstrate very good effect to P388 Lymphocytic leukemia and B16 melanoma.Be tangible to the melanomatous high reactivity of B16 especially.
The activity of finding is strange especially, because most compounds is cationogen and corresponding cationogen ammonia-platinum complex.And these complex compounds known be not have anti-tumor activity.
Relevant bibliographic reference.Nelson etal., J.Chem.Soc., Dalton trans., 1778(1975), introduce that two (suitable-1, two (phenylbenzene-phosphino-ethene) the dichloro iron (II) of 2-and two (along 1,2-pair of (phenylbenzene-phosphino-) ethene) dichloro iron (III) tetrachloro are for ferrate (III).Sacconi et al., Inorg.Chem., 20,3423(1981), introduced the X-ray crystalline texture of iron above-mentioned (II) complex compound.Chatt et al., J.Chem.Soc. 5504(1961), discloses two (1, two (phenylbenzene-phosphino-) ethane of 2-) bromine cobalt (II) bromide.Sacco et al.Gazz.Chim.Ital., 93,687(1963), disclose several two (1, two (phenylbenzene-phosphino-) ethane of 2-) cobalt (II) complex compounds (among other, bromide, iodide, perchlorate, nitrate) and two (1, two (the diphenylphosphino)-ethane of 2-) nickel (II) two perchlorate.Schmid et al., Z.Naturforsch., 20b 1008(1965), disclosed two (1, two (diphenylphosphino) ethane of 2-) chlorine cobalt (II) muriate.Sacco et al., J.Chem.Soc. 3274(1964), has disclosed two (1, two (diphenylphosphino) ethane of 2-) rhodium (I) muriate and its perchlorate and tetraphenyl borate resemblance.Arnold et al., Chem, Phys, Lett., 19,546(1973), disclosed two (1, two (diphenylphosphino) ethane of 2-) dichloro rhodium (III) muriate.Hieber et al., Chem.Ber., 99,2607(1966), disclosed two (1, two (diphenylphosphino) ethane of 2-) iridium (I) muriate, Sacco et al, J.Chem.Soc.Chem.Comm., 589(1966), disclosed several two (1,2-two (diphenylphosphino ethane)) iridium (I) complex compound (muriate, bromide, iodide, perchlorate) and two (1, two (diphenylphosphino) ethane of 2-) peroxidation iridium (III) perchlorate.Above this compound by G.Rouschias et al; J, Chem.Soc., Dalton Trans. 2531(1974) has done more detailed introduction.Chatt et al; J.Chem.Soc., 2537(1962), two (1, two (diphenylphosphino) ethane of 2-) nickel (II) dinitrates and two (1, two (diphenylphosphino) ethane of 2-) palladium (II) dibromide have been disclosed.Feltham et al., J.Chem.Soc. 4587(1964) has disclosed two (1, two (diphenylphosphino) ethane of 2-) palladium (II) two perchlorate.Westland, J.Chem Soc.A. has disclosed several two (1, two (diphenylphosphino) ethane of 2-) palladium (II) complex compounds (muriate, bromide, iodide, perchlorate) in 3060(1965).Struck et al, J.Med.Chem., 9,414(1966) disclosed 1, the cytotoxic activity of two (diphenylphosphino) ethane of 2-, this compound are used as initial substance usually and prepare the active ingredient of most drug composition and the methods of treatment of theme invention.
Above-mentioned bibliography none discloses or suggestion is pharmaceutical composition or present methods of treatment of inventing.
At european patent application 0151046(date of application 31.01.1985) Hill, Johoson and Mirabelli have disclosed application (a-is position-two (two replace phosphino-)-hydrocarbon not) two gold medals (I), two gold medals (III), the derivative of two silver medals (I) and two bronze medals (I) is treated the antineoplastic pharmaceutical compositions and the compound of tumour.
At european patent application 0164970(date of application 31.05.1985) in Berners-Price, Mirabelli, Johoson and Sadler have further disclosed pharmaceutical composition, these compositions are to contain (two (two (diphenylphosphino) hydrocarbon), (two (two (diethyl phosphino-) hydrocarbon)-and two ((diphenylphosphino-diethyl phosphino-) hydrocarbon), gold (I), silver (I) and copper (I) complex compound or three-(two (diphenylphosphino) ethane) two bronze medals (I) complex compound.
, some VIII family metal complexs are not introduced or are proposed in these bibliographys, and they can demonstrate cytotoxin or any other pharmaceutical activity.
Not all composition drops in the general formula 1 and all is fine.Compound (Ni Cl(diphos) for example
2)
1Cl
-Just can not synthesize.(see R.Morassi and A.Dei, Inorg.Chim.Acta, 6,314(1972)).
Further observe, owing to the well-known reason of the people that are familiar with coordination chemistry, some binding substancess can not exist, and for example working as metal is that palladium (II) and negatively charged ion are Cl
-The time, a 4-coordination and X are arranged
1And X
2Can not exist.When negatively charged ion is Br
-The time, can there be (5-coordination) in 1X and 1Y, and when negatively charged ion was I, 2X existed and can not there be (6-coordination) in Y, when negatively charged ion is Cl O
- 4The time X can not exist and two Y(4-coordinations can be arranged).Yet, be tangible for possibility the people that this technical field is familiar with.
Specification sheets
The present invention especially provides formula 1 compound, wherein
D
1=D
2=phosphorus or D
1=phosphorus and D
2=arsine;
A=(CH
2)
2Or suitable-CH=CH or (CH
2)
3;
X
1=X
2(as the two word that all exist)=halogen or nitroxyl or X
1+ X
2=peroxidation base;
Y(is as existing)=fontanel is for thing, nitrate, and perchlorate, triflate or four fontanels are for ferrate (III);
N=0,1 or 2,
The M=Fe(II), the Fe(III), the Co(II) and, the Rh(I), the Rh(III) and, the Ir(I), the Ir(III) and, the Ni(II) or the Pd(II), regulation is when the M-Fe(II) time, D
1-D
2-phosphorus, A=is suitable-CH=CH, X
1=X
2=fontanel base and n=0; Further regulation is when the M=Fe(III) time, D
1=D
2=phosphorus, A=is suitable-CH=CH, X
1=X
2=fontanel base and Y=four fontanels are for ferrate (III); Further regulation is when the M=Co(II) time, D
1=D
2=phosphorus or D
1=phosphorus and D
2=arsenic, A=(CH
2)
2Or suitable-CH=CH, X
1=fontanel base or nitroxyl, n=1 and Y=fontanel be for thing, nitrate, perchlorate or triflate or n=2 and Y=perchlorate or triflate; Further regulation is when the M=Rh(I) or the Ir(I), D
1=D
2=phosphorus, A=(CH
2)
2Or suitable-CH=CH, n=1 and Y=muriate, nitrate, perchlorate or triflate or X=bromine or iodine and n=0; Further regulation is when the M=Rh(III) or the Ir(III) time, D
1=D
2=phosphorus or D
1=phosphorus and D
2=arsenic, A=(CH
2)
2Or suitable-CH=CH, X
1=X
2=fontanel base or X
1+ X
2=peroxidation base, n=1 and Y=fontanel be for thing, nitrate, perchlorate or triflate; Further regulation is when the M=Ni(II) time, D
1=D
2=phosphorus or D
1=phosphorus and D
2=arsenic, A=(CH
2)
2Or suitable-CH=CH, X
1=bromo or iodo, n=1 and Y=bromide, iodide, nitrate or triflate or n=2 and Y=nitrate, perchlorate or triflate; Further regulation is when the M=Pd(II) time, D
1=D
2=phosphorus or D
1=phosphorus and D
2=arsenic, A=(CH
2)
2Or suitable-CH=CH, X
1=X
2=iodo and n=0, or X
1=bromo, n=1 and Y=bromide, nitrate, perchlorate or triflate, n=2, Y=muriate, nitrate, perchlorate, triflate.The active compound of mentioning form above be known also be can be by the method preparation that realizes easily for the people who is familiar with this field.Unless stipulate other, the industrial source for preparing the essential initiator of these compounds is easy to get.1, two (diphenylphosphino) ethane of 2-are defined as diphos, and 1-diphenyl phosphine-2-hexichol arsino ethane is arphos and suitable-1, and two (diphenyl phosphine) ethene of 2-are dppen.Preparation iron (II) complex compound, 2 molar equivalent dppen and 1 molar equivalent left and right sides iron (II) fontanel are raised to reflux temperature with temperature for thing and react in ethanol.Iron (III) complex compound can by with 1 molar equivalent deppn and 1 molar equivalent iron (III) fontanelle compound in the mixture of ethanol and acetone 70 ℃ of following prepared in reaction.
Produce cobalt (II) complex compound, suitable cobalt (II) reactant salt of the proper fit body of 2 molar equivalents and 1 molar equivalent, selection provides the inorganic group X and the negatively charged ion (Y) of the covalent bonding of expectation; Be reflected in the ethanol under the reflux temperature (the X=Y=fontanel is for thing) or in acetone under the room temperature (for example X=Y=nitrate and Y=two perchlorate) carry out.
Preparation rhodium (I) complex compound, there is SOME METHODS to realize for the people who is familiar with this field, example passes through at first from (suitable, suitable-1, the 5-cyclooctadiene) rhodium chloride (I) dipolymer, methyl ethyl diketone and potassium hydroxide in ether at-70 ℃ to the synthetic initiator of room temperature (suitable, suitable-1,5-cyclooctadiene) rhodium (I) acetoacetate; This product of 1 molar equivalent reacts the complex compound that obtains to have the Y=perchlorate with 70% perchloric acid of 1 molar equivalent and the suitable dentate (diphos or dppen) of 2 molar equivalents under the boiling temperature in tetrahydrofuran (THF) then.Rhodium (I) complex compound that has Y=triflate passes through the (suitable of 1 molar equivalent, suitable-1, the 5-cyclooctadiene) the silver-colored triflate of rhodium chloride (I) dipolymer and 2 molar equivalents is in acetone, after the silver chloride that forms is removed, again with suitable dentate (diphos or the dppen) prepared in reaction of 2 molar equivalents.
Obtain rhodium (III) and iridium (III) complex compound, rhodium of 1 molar equivalent (III) or iridium (III) fontanel react with the suitable dentate of 2 molar equivalents under the reflux temperature in ethanol for thing, and this reaction provides and had X
1=X
2=Y=fontanel is for the compound of thing, and these compounds can be transformed into and have X
1=X
2The complex compound of=fontanel base and Y=perchlorate is to handle by dissolving them in the mixture of second alcohol and water, being right after with excessive sodium perchlorate.
The method preparation that iridium (I) complex compound can be known by the people that are familiar with this field.For example in benzene under the reflux temperature (suitable, suitable-1,5-cyclooctadiene) iridium chloride (I) dipolymer of the suitable dentate of 4 molar equivalents (diphos or dppen) and 1 molar equivalent mix; Obtain to have the muriatic compound of Y=like this and can be transformed into resemblance, for example by dissolving they can obtain the Y=perchlorate then with excessive sodium perchlorate precipitation in methyl alcohol compound.
Iridium (I) and rhodium (I) complex compound all can by with air one oxygen at room temperature in the methylene dichloride reaction be transformed into and have X
1+ X
2The metal of=peroxidation base (III) resemblance.
Preparation nickel (II) complex compound, nickel (II) reactant salt that the suitable dentate of 2 molar equivalents and 1 molar equivalent are suitable; Be reflected in the mixture of second alcohol and water under the boiling temperature (X=Y=fontanel base, rather than chloro or Y=dinitrate) or in acetone under the room temperature (Y=two perchlorate) carry out.
Palladium (II) complex compound that has the Y=dichloride reacts under the reflux temperature in benzene by the suitable dentate of two-(acetonitrile) palladium chloride (II) and 1 molar equivalent, prepares by reacting down for 80 ℃ at dimethyl formamide with similar normal dentate then.This compound can be transformed into resemblance.For example by dissolving it in the mixture of second alcohol and water, obtain having the compound of Y=perchlorate then with excessive rare perchloric acid precipitation, also can at room temperature this solution be added in the solution that contains excessive sodium iodide in the water then, obtain having X by dissolving it in the mixture of second alcohol and water
1+ X
2The resemblance of=iodide.
This invention also relates to pharmaceutical composition, it is characterized in that effectively suppressing the active ingredient and the inert agents of growth of tumour cell amount, medicine acceptable carrier or thinner, wherein said composition is generally used for suppressing the animal tumor cell growth to the active ingredient sensitivity, and wherein active ingredient is mentioned the compound of form above being.
Vitro cytotoxicity
The cytotoxic activity of metal complex is estimated in the external B16-F10 of being used for mouse melanoma cell and HCT-116 human colon cancer cell.The B16-F10 cell strain is to remain on Eagle minimal essential medium (MEM) lining of containing Earle salt (Gibco).2 mmole L-glutaminate are arranged in the substratum, 2.06 mmole Sodium.alpha.-ketopropionate, Regular Insulin (0.26 units per ml), penicillin/streptomycin (is respectively 100 units per ml and 100 μ g/ milliliters, MEM non-essential amino acid (0.6% Gibco) and 10% foetal calf serum (Hyclone).The Hc T-116 cell (modified version of in Mc Co Y ' s5 A substratum, growing, Gibco), 2 mmole L-glutaminate are arranged in the substratum, 0.12 mmole L-Serine, 0.17 mmole asparagine, 1.5 mmole Sodium.alpha.-ketopropionate, MEM indispensable amino acid (0.625%, Gibco), the MEM non-essential amino acid (0.67%, Gibco), contain vitamin(e) M EM(0.6%, Gibco) foetal calf serum (10%, Hyclone) and penicillin/streptomycin (be respectively 100 units per ml and 100 μ g/ milliliters.Two kinds of cell strains all contain 5% CO at 37 ℃
2Hatch in the high humidity thermostat container.
The cell of logarithmic growth obtains by the trysinization of appropriateness, and per 4000 cells are added in each hole slot of 96 holes trace titre plate.This plate is at 37 ℃ of 5% CO
2Spend the night in the incubator, allow cell attachment to plate.Cell is handled and was hatched 72 hours with metal complex or cisplatin then.Plate put upside down and shake remove substratum, medicine and isolated cells.Add 10% formalin phosphate buffered saline buffer, fixed cell 10 minutes.Sticking agent is removed, the culture dish dry air, with 0.0075% violet staining 15 minutes, washed twice is dry air then, and dyestuff is with 0.2ml/ volumetric molar concentration AcoH/EtoH(1: 1) dissolving and spectrodensitometry are with the micro-titre dish of a kind of Dynatech MR600 reader.IC50 calculates according to the linear regression analysis of absorption data.
Several compounds see Table 1 in the test-results of vitro cytotoxicity.
Anti-murine leukemia activity
All metal complexs have all been done the anti-tumor activity test to the P388 murine leukemia.The compound of selecting has also been done L1210 murine leukemia anti-tumor activity test and L1210 murine leukemia cell substrain to dichloro diamino platinum (L1210: resistant test DDP).The CDF of 20 grammes per square metres
1Inoculation 10 in the mouse peritoneum
6Individual P388 leukemia cell, the leukemic ascites cells of L1210 leukemia or L1210: DPP, this experimental evidence is the pilot system of usefulness.To begin day be transplantation tumor and then in administration in the whole test method.Complex compound is with various various dose peritoneal injections.
Each dosage group is with 4 to 6 mouse, and these mouse were only treated once with complex compound the same day.Each experiment includes one group 10 the contrast mouse with brine treatment.In each experiment, comprise positive controls with the platinum diamminodichloride treatment.Mouse is weighed before treatment, weighs in 5 or 6 days then again, and the variation of their weight in averages is used to measure toxicity.The mortality ratio of observing animal every day 30 days was an experimental period.
Anti-tumor activity is measured according to %T/C, and T/C% takes advantage of 100 with brine treatment group survival time ratio the medication therapy groups survival time.Have P388 leukemia cell and be generally 9 days with the mouse survival time median of brine treatment.Having L1210 and L1210/DDP leukemia cell's survival time is 7 days.If a kind of complex compound can produce 〉=125 T/C percentage, be considered to have activity.
The extensive overview of table II and II a to the evaluation of murine leukemia active compound for anti tumor.What each compound was listed is maximum T/C% that obtains and the dosage that produces this effect.
Anti-B16 melanoma activity
Several metal complexs are to the additional evaluation of the melanomatous anti-tumor activity of B16.
The BOF mouse, 10 every group, intraperitoneal inoculation 0.5ml 10%(W: V) the melanomatous oar of B16 is stuck with paste.Transplant and begin one day after to carry out continuing altogether the Ninth Heaven every day with the treatment of metal complex intraperitoneal.4 to 5 dosage of each compound test.Each experiment comprises brine treatment control group and platinum diamminodichloride treatment group.Observe the survival number of mouse every day, 60 days is an experimental period.The brine treatment control group shows that the median of mouse survival time is 20～26 days.
The survival time median of pharmacological agent mouse is compared with the control than (%T/C) a kind of measurement as anti-tumor activity.If a complex compound generation 〉=125%T/C so just thinks that it has activity.
The experimental result of metal complex is summarised in the table III, maximum %T/C that each complex compound that the table III is enumerated is obtained and the dosage that produces this effect.
Medication preparation
For the research of vitro cytotoxicity, their solubleness of drug dependence is dissolved or suspended in 0.9% sodium chloride solution.Use 5% D/W or 10%DMSO0.9% sodium chloride solution once in a while.The compound that preparation is used for interior therapeutic is by adding a small amount of Tween80, with compound dissolution or be suspended in the water.
Example
Below case description the chemical preparation of compound and method of the present invention and be not limited in minimum scope in the composition.All reactions all are to carry out in drying nitrogen.1, two (diphenylphosphino) ethane of 2-are defined as diphos, and 1-diphenyl phosphine-2-diphenylarsine ethane is defined as arphos and along 1, two (the hexichol phosphorus base) ethene of 2-are defined as dppen.
Example 1
Two [suitable-1, two (diphenyl phosphine) ethene of 2-] ferrous chloride (II) with formula 8.
Anhydrous Ferric Chloride II (0.2536g with heat filtering in the 30ml ethanol (70 ℃), 2mmol) solution is added to ebullient dppen(1.584g in 60ml ethanol, 4mmol) in the solution, the suspension of reaction stirred 1 hour at boiling temperature, behind the cool to room temperature, product leaches, with ethanol and ether washing, then 50 ℃ of vacuum-dryings.
Output: 1.74g yellow solid (95.1% weight)
Molten point: 275 °～278 ℃
Analyze (weight %):
Theoretical value: C67.92 H4.79 Cl 7.72
Trial value: C68.00 H4.99 Cl 7.71
Example 2
Two [suitable-1, two (diphenyl phosphine) ethene of 2-] ferrous chloride (III) tetrachloro with formula 20 is for ferrate (III).
(0.4866g, 3mmol) methanol solution is added at 70 ℃ and contains dppen(1.485g 15ml iron(ic) chloride (III), in 3.75mmol) the 15ml acetone and 15ml methanol mixture.The green suspension that obtains stirs 1 hour cool to room temperature then at 70 ℃.After placement is spent the night, leach product, product is with methyl alcohol, benzene, ether washing, then 50 ℃ of vacuum-dryings.
Output: 1.56g green solid (93.4% by weight)
Molten point: 200 °～202 ℃
Analyze (% is by weight):
Theoretical value: C55.89 H3.94 Cl 19.05
Trial value: C56.79 H4.23 Cl 18.85
Example 3
Two [1, two (diphenyl phosphine) ethane of 2-] bromine cobalt (II) bromide with formula 14.
(1.2g, 10ml methanol solution 3.673mmol) is added to and contains diphos(3g, in 50ml methanol suspension 7.5376mmol) to contain cobaltous bromide (II) hexahydrate.Obtain black brown-green suspension stirring at room 1 hour, under boiling temperature, stirred 0.5 hour then.Filtering almost limpid solution evaporates then.Residue uses hydrate alcohol (1: 3) recrystallization then 60 ℃ of vacuum-dryings.
Output: 2.65g blackish green solid (by weight, 71.6%)
Molten point: 120 °～125 ℃
Analyze (% by weight):
Theoretical value (+2 ethanol): C60.72 H5.42 Cl 14.44
Experimental value: C60.89 H5.29 Cl 14.17
Example 4
Two [1, two (diphenyl phosphine) ethane of 2-] Xiao Suangu (II) with formula 4.
Xiao Suangu (II) salt hexahydrate (0.518g, 20ml acetone soln 2mmol) follow agitation and dropping to containing diphos(1.99g, in 40ml acetone suspension 5mmol), and time-consuming 15 minutes.Obtain limpid brown solution and be concentrated to 20ml in 1 hour then in stirring at room.Add about 100ml ether, filter the brown precipitate that forms, wash with ether then.Product with acetone recrystallization then 60 ℃ of vacuum-dryings.
The dark brown solid of output: 1.21g (62.1% by weight)
Fusing point: 138 °～140 ℃.
Analyze (% by weight)
Theoretical value: C63.16 H4.96 N2.83 O10.53
Experimental value: C63.42 H5.46 N2.56 O10.65
Example 5
Two [1, two (diphenyl phosphine) ethane of 2-] cobalt (II) two perchlorate with formula 16.
Cobalt (II) perchlorate hexahydrate (1.5g, 40ml acetone soln 4.1mmol) follow agitation and dropping to containing diphos(4.1g, in 80ml acetone suspension 10.3mmol), and time-consuming 15 minutes.The yellow suspension that obtains was stirring at room 1.5 hours.Product leaches then, uses the washing with acetone product then at 100 ℃ of vacuum-drying products.
Output: 4.25g yellow solid (by weight 98.4%)
Fusing point: 235 °～240 ℃.
Analyze (% by weight)
Theoretical value: C59.21 H4.56 Cl 6.73
Experimental value: C59.31 H4.67 Cl 6.56
Example 6
Two-[1-diphenyl phosphine-2-two arsenobenzene ethane] cobalt (II) two perchlorate with formula 21.
The product of the preparation of this title product and example 5 names is similar on mode, raw material be cobalt (II) perchlorate hexahydrate (0.732g, 2mmol) and arphos(1.77g, 4mmol).
Output: 0.53g yellow solid (23.2% by weight)
Fusing point: ± 225 ℃ (decomposition)
Analyze (% by weight)
Theoretical value (+0.5 water): C54.23 H4.29 Cl 6.16
Experimental value: C54.19 H4.26 Cl 6.13
Example 7
Two [1, two (diphenyl phosphine) ethane of 2-] rhodium (I) triflate with formula 9.
15ml silver (I) triflate(1.02g, 3.97mmol) acetone soln be accompanied by agitation and dropping to (suitable, suitable-1, the 5-cyclooctadiene) rhodium chloride (I) dipolymer (0.9856g, in 10ml acetone suspension 2mmol), time-consuming 10 minutes, in the dark stir 2 hours after, the silver chloride (I) that leaches formation is used washing with acetone then.Diphos(3.58g then, 15ml acetone solution 9mmol) is added in the filtrate, and stirring at room 1 hour, volume was concentrated to 15ml then then.Drip the 60ml ether, the suspension that obtains then spends the night+3 ℃ of storages.Product leaches, with the ether washing, then in vacuum-drying.
Output: 3.96g yellow solid (95% by weight)
Fusing point: 225 °～230 ℃
Analyze (% by weight)
Theoretical value: C60.69 H4.58 S3.06 F5.44 P11.83
Experimental value: C60.49 H4.73 S2.93 F5.31 P10.99
Example 8
Two-[1, two (diphenyl phosphine) ethane of 2-] rhodium (I) perchlorate with formula 10.
3.35ml methyl ethyl diketone (3.255g, 32.55mmol) be added to (suitable, suitable-1, the 5-cyclooctadiene) rhodium chloride (I) dipolymer (8.2g, 16.27mmol) 90ml ether suspension in, suspension is cooled to-80 ℃ then, then with following agitation and dropping 19ml potassium hydroxide (5.478g, 97.65mmol) aqueous solution in 30 minutes.Do not add cooling and continue to stir, then stirring at room 4 hours up to arriving room temperature.Add 25ml water and 200ml benzene then.The organic layer that obtains produce the 8.4g yellow solid (83.3%, methyl ethyl diketone rhodium (I) by weight)=(suitable, suitable-1,5-cyclooctadiene).
Top preparation is (suitable, suitable-1,5-cyclooctadiene) methyl ethyl diketone rhodium (I) (0.62g, 2.02mmol) solution and in the 15ml tetrahydrofuran (THF) 70% perchloric acid (0.287g, 2mmol) be added to and contain drphos(1.67g, in 10ml tetrahydrofuran (THF) 4.2mmol).The suspension that obtains stirred 2 hours at boiling temperature in stirring at room in 0.5 hour then.Cooling back volume reduces to 10ml, spends the night-20 ℃ of storages, and product leaches then, with the ether washing, uses methylene dichloride/tetrahydrofuran (THF) recrystallization then 50 ℃ of vacuum-dryings.
Output: 1.68g orange solid (84% by weight)
Fusing point: 282 ℃
Analyze (% by weight)
Theoretical value: C62.51 H4.81 Cl 3.55 O6.41
Experimental value: C62.43 H4.83 Cl3.57 O6.22
Example 9
Two-[1, two (diphenyl phosphine) ethane of 2-] dichloride rhodium (III) with formula 17.
With Diphos(3.016g, 7.5756mmol) follow stirring to be added to rhodium chloride (III) trihydrate (0.8g is in 65ml ethanol boiling solution 3.0388mmol) in batches.The brown suspension that obtains stirred 3 hours under boiling temperature.Almost limpid then solution activated carbon treatment, heat filtering then; Liquor capacity reduces to 15ml, slowly adds ether then, be cooled to then+3 ℃ obtain product.Product leaches, and with the ether washing, product is dry in a vacuum then.
Output: 1.37g yellow solid (44.9% by weight)
Fusing point: 265 °～270 ℃
Analyze (% by weight)
Theoretical value: (+3 ethanol): C60.88 H5.77 Cl 9.30 O4.20
Experimental value: C60.64 H5.68 Cl 9.06 O3.68
Example 10
Two-[1, two (diphenyl phosphine) ethane of 2-] dichloride rhodium (III) perchlorate with formula 15.
(1.07g 7.597mmol) is dissolved in and follows agitation and dropping in the 5ml water (1.527g, in boiling solution 1.519mmol), time-consuming 10 minutes, the product of example 9 names was dissolved in the mixture of 50ml ethanol and 25ml water to example 9 name products sodium perchlorate-hydrate.The suspension that obtains is+5 ℃ of preservations of spending the night; Product leaches then, and is with ethanol and water washing, with methylene dichloride/tetrahydrofuran (THF) recrystallization, dry in 90 ℃ of vacuum.
Output: 1.0g yellow solid (61.7% by weight)
Theoretical value: C58.36 H4.49 Cl9.95
Experimental value: C58.15 H5.13 Cl9.75
Example 11
Two [1-diphenyl phosphine-2-diphenylarsine] dichloride rhodiums (III) with formula 23.
The product of this name is similar to the product preparation method of name in the example 9, just must stir 15 hours at boiling temperature.Raw material is arphos(3.32g, 7.5mmol) and rhodium chloride (III) triflate(0.79g, and 3.0mmol).
Productive rate: 2.7g yellow solid (82.3% calculates by weight)
Fusing point: 265 °～270 ℃ (decomposition)
Analyze (% by weight)
Theoretical value (+1.5 water): C55.71 H4.59 Cl 9.49
Experimental value: C55.67 H4.54 Cl 9.04
Example 12
Two-[1-diphenyl phosphine-2-diphenylarsine ethane] dichloride rhodium (III) perchlorate with formula 18.
(0.7g, (1.0g, in boiling solution 0.914mmol), time-consuming 10 minutes, the name product of example 11 was dissolved in the 100ml ethanol 5mmol) to follow agitation and dropping to arrive example 11 name products to be dissolved in sodium perchlorate-hydrate in the 5ml water.The suspension that obtains spends the night+5 ℃ of preservations; Leach product then, water washs fully, washes with ethanol and ether then, then in vacuum-drying.
Output: 0.72g dark yellow solid (67.9% by weight)
Fusing point:＞310 ℃ (decomposition)
Analyze (% by weight)
Theoretical value (+1 water): C53.11 H4.29 Cl 9.04 O6.80
Experimental value: C52.90 H4.42 Cl 8.57 O6.42
Example 13
Two-[1, two (diphenyl phosphine) ethane of 2-] perchloric acid iridium (I) with formula 13.
Diphos(1.26g, (0.506g is in solution 0.754mmol) for iridium chloride (I) dipolymer 3.16mmol) to be added to (suitable, suitable-1,5-cyclooctadiene) that is dissolved in the 10ml benzene.The suspension that obtains stirred 3 hours at boiling temperature.Behind the cool to room temperature, suspension spends the night+60 ℃ of preservations.Leach tangerine look solid then,, be dissolved in then in the 30ml ethanol with the benzene washing.Add sodium perchlorate, (0.96g, 6.838mmol), the suspension that obtains spent the night-20 ℃ of preservations in stirring at room hydrate in 3 hours then.Leach product, with ethanol and water washing, with methylene dichloride/ether recrystallization, then 100 ℃ of vacuum-dryings.
Output: 1.12g tangerine look solid (68.7% by weight)
Fusing point: 215 °～220 ℃
Analyze (% by weight)
Theoretical value: C57.37 H4.41 Cl 3.26 O5.88
Experimental value: C57.50 H4.73 Cl 3.28 O6.09
Example 14
Two-[1, two (diphenyl phosphine) ethane of 2-] peroxidation base perchloric acid iridium (III) with formula 22.
Be dissolved in 13 names of example in the 25ml methylene dichloride product solution (2.44g, 2.2468mmol) huge strong stirring 1 hour in air adds 75ml ethanol then, the solution that obtains then slowly is evaporated to 10ml, leach sedimentary product, use washing with alcohol, 80 ℃ of vacuum-dryings.
Output: 1.9g is shallow-tangerine look solid (75.7% by weight)
Fusing point: 230 °～235 ℃ (decomposition)
Analyze (% by weight)
Theoretical value: C55.73 H4.29 Cl 3.17 O8.57 P11.83
Experimental value: C55.79 H4.26 Cl 3.16 O8.84 P10.97
Example 15
Two [1, two (diphenyl phosphine) ethane of 2-] nickel (II) dinitrate with formula 5.
With Diphos(4.0g, (1.45g, 4.99mmol) in the solution, nickelous nitrate (II) hexahydrate is dissolved in the 50ml ethanol 10.05mmol) to be added to nickelous nitrate (II) hexahydrate.The suspension that obtains then stirred 0.5 hour at boiling temperature stirring at room 1 hour.Then water is added to ebullient suspension and dissolves up to most solid, solution heat filtering then, postcooling is to-20 ℃ again.Leach sedimentary product, then with the ether washing, with hydration ethyl alcohol recrystallization twice, 90 ℃ of vacuum-dryings.
Output: 1.0g tangerine look solid (20.5% by weight)
Fusing point: 217 °～230 ℃
Analyze (% by weight)
Theoretical value: C63.76 H4.91 N2.91
Experimental value: C63.33 H5.03 N2.79
Example 16
Two-[1, two (diphenyl phosphine) ethane of 2-] nickelous perchlorate (II) with formula 19.
Be dissolved in nickelous perchlorate (II) hexahydrate in the 20ml acetone (0.731g, 2mmol) solution follows agitation and dropping to the diphos(1.633g that is dissolved in the 40ml acetone, 4.1mmol) in the suspension, time-consuming 30 minutes.The suspension that obtains was stirring at room 3.5 hours.Leach product then, use the washing with acetone product, then at the vacuum-drying product.
Output: 1.87g yellow solid (88.6% by weight)
Fusing point: 248 ℃
Analytical results (weight percent)
Theoretical value: C59.23 H4.59 Cl 6.73
Experimental value: C59.22 H4.74 Cl 6.47
Example 17
Two [1, two (diphenyl phosphine) ethane of 2-] palladium chloride (II) with formula 2.
Be dissolved in the diphos(1.83g in the 25ml benzene, 4.6mmol) (1.17g, suspension 4.51mmol) stirred 3 hours at boiling temperature with two (acetonitrile) palladium chlorides (II).After the cooling, evaporation suspension, residue dimethyl formamide then: ether recrystallization.Then recrystallized product is dissolved in dimethyl formamide at 80 ℃.Add diphos(1.63g then, 4.095mmol).This mixture after 1 hour, is added ether in stirring at room, leach precipitation then,, use the dimethyl formamide recrystallization then with the ether washing.
Output: 2.06g white solid (47% weight percent)
Fusing point: 283 °～300 ℃
Analytical results (weight percent)
Theoretical value: C64.06 H4.96 Cl 7.27
Experimental value: C63.7 H5.0 Cl 6.91
Example 18
Two [1, two (diphenyl phosphine) ethane of 2-] palladium diiodide (II) with formula 11.
Be dissolved in the example 17 in 25ml ethanol and the 5ml water mixture name product (1.46g, 1.5mmol) solution follow agitation and dropping to be dissolved in sodium iodide in the 20ml water (7.495g, 50mmol) in the solution, time-consuming 10 minutes.Obtain suspension stirring at room 1 hour, leach product then, wash with water, then at 300ml water: boiling is 0.5 hour in the ethanol (1: 1); After the cooling, suspension spends the night+3 ℃ of preservations; Leach product, water, ethanol and ether washing are 100 ℃ of vacuum-dryings.
Output: 1.22g light yellow solid (70.5% by weight)
Fusing point: 281.5 °～284.5 ℃
Analytical results (weight %)
Theoretical value: C53.97 H4.15 I21.95
Experimental value: C53.32 H4.21 I21.29
Example 19
Two [1, two (diphenyl phosphine) ethane of 2-] two perchloric acid palladiums (II) with formula 12.
Be dissolved in perchloric acid in the 25ml water (1.44g, 10mmol) solution follow agitation and dropping to be dissolved in 20ml ethanol and the 5ml water mixture product of name in the example 17 (0.97g, 1mmol) in the solution, time-consuming 10 minutes.The suspension that obtains was stirring at room 2 hours.Leach product then, wash with water, 100 ℃ of vacuum-dryings.
The white yellow solid of output: 0.83g (75 weight %)
Fusing point: 328 °～333 ℃ (decomposition)
Analytical results (weight %)
Theoretical value (+1 water): C55.75 H4.47 Cl 6.33
Experimental value: C55.5 H4.7 Cl 6.3
Example 20
Two [1, two (diphenyl phosphine) ethane of 2-] dinitric acid palladium (II) with formula 3.
Be dissolved in saltpetre in the 5ml water (1.26g, 2.59mmol) solution follow agitation and dropping to be dissolved in example 17 name products in the 50ml warm water (1.26g, in solution 2.59mmol), about 2 minutes of time.The suspension that obtains was stirring at room 2 hours.Leach product then, wash with water, 100 ℃ of vacuum-dryings.
Output: 0.75g white solid (59.5 weight %)
Fusing point: 270 °～280 ℃ (decomposition)
Analytical results (weight %)
Theoretical value: C60.80 H4.68 N2.73 O9.35
Experimental value: C60.56 H4.57 N2.47 O9.11
Example 21
Two [1, two (diphenyl phosphine) ethane of 2-] palladium bromide (II) with formula 7.
Diphos(2.0g, 5.025mmol) (0.455g 2.566mmol) seethed with excitement 10 minutes under refluxing with being dissolved in 50ml alcoholic acid Palladous chloride (II).The solution cooling that obtains then is then with the Sodium Bromide of following the excessive hydration of agitation and dropping in 15 minutes.The suspension that obtains leaches product then stirring at room 1 hour, washes product with water, uses the hydration ethyl alcohol recrystallization then, at the vacuum-drying product.
Output: 1.30g is light yellow solid (48.2 weight %) very
Fusing point: about 240 ℃ (decomposition)
Analytical results (weight %)
Theoretical value: C58.26 H4.61 Br 14.91
Experimental value: C58.32 H4.75 Br 14.61
Example 22
Two [suitable-1, two (diphenyl phosphine) ethane of 2-] palladium chloride (II) with formula 6.
Dppen(1.584g, 4mmol) (0.3546g 2mmol) seethed with excitement 0.5 hour under refluxing, and the almost limpid solution that obtains spends the night, and then liquor capacity is reduced to 15ml with being dissolved in 50ml alcoholic acid Palladous chloride (II).This solution spends the night-20 ℃ of preservations, leaches the crystalline product then, with ethanol and ether washed product, at 90 ℃ of vacuum-drying products.
The cream-colored solid (33.7 weight %) of output: 0.65g
Fusing point:＞320 ℃ (decomposition)
Analytical results (weight %)
Theoretical value (+2 water): C62.07 H4.78 Cl 7.05
Experimental value: C62.43 H4.73 Cl 7.05
Example 23
The compound that carries out vitro cytotoxicity research is dissolved or suspended in 0.9% sodium chloride solution according to their solubleness.Sometimes use 5% D/W or 10%DMSO0.9% sodium chloride solution.The compound that is used for interior therapeutic is dissolved or suspended in water and prepares by adding a small amount of Tween80.
Claims (1)
1, the method for preparing the following formula pharmaceutical active compounds
D=phosphine wherein, negatively charged ion is the trifluoromethane sulfonic acid root, M=R
h(III),
This method feature is: in acetone, with the trifluoromethane sulfonic acid root with (suitable, suitable-1,5-cyclooctadiene rhodium chloride (I) dipolymer reaction, and then toward wherein adding 1,2-two (diphenyl phosphine ethane) reacts.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8502929 | 1985-10-25 | ||
| NL8502929A NL8502929A (en) | 1985-10-25 | 1985-10-25 | GROUP VIII TRANSITION METAL COMPLEXES, METHOD FOR PREPARING THEREOF, METHOD FOR PREPARING A MEDICINAL PRODUCT USING SUCH GROUP VIII TRANSITION METAL COMPLEX FOR THE TREATMENT OF SUCH AS AT THE SAME TIME, PROVENLY AT THE COURT. |
| CN198686107219A CN86107219A (en) | 1985-10-25 | 1986-10-25 | The phosphino-hydrocarbon-group VIII-metal complexes of pharmaceutical activity contains the method for anti-tumor compositions and preparation these complex compounds or the anti-tumor compositions of these complex compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN198686107219A Division CN86107219A (en) | 1985-10-25 | 1986-10-25 | The phosphino-hydrocarbon-group VIII-metal complexes of pharmaceutical activity contains the method for anti-tumor compositions and preparation these complex compounds or the anti-tumor compositions of these complex compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1068573A true CN1068573A (en) | 1993-02-03 |
Family
ID=25742258
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 92104055 Pending CN1068573A (en) | 1985-10-25 | 1992-05-25 | Preparation phosphino-hydrocarbon-group VIII-metal complexes and contain the anti-tumor compositions method of these complex compounds |
| CN 92104056 Pending CN1069275A (en) | 1985-10-25 | 1992-05-28 | Preparation phosphino-hydrocarbon-group 8-metal complexes and contain the anti-tumor compositions method of these complex compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 92104056 Pending CN1069275A (en) | 1985-10-25 | 1992-05-28 | Preparation phosphino-hydrocarbon-group 8-metal complexes and contain the anti-tumor compositions method of these complex compounds |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN1068573A (en) |
-
1992
- 1992-05-25 CN CN 92104055 patent/CN1068573A/en active Pending
- 1992-05-28 CN CN 92104056 patent/CN1069275A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1069275A (en) | 1993-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parulekar et al. | Structural chemistry of organotin carboxylates: II. The crystal structure of the dicarboxylato tetraorganodistannoxane:{sunBu2Sn (O2CC5H4N)] 2O} 2 | |
| US4562275A (en) | Antitumor platinum complexes | |
| Cabeza et al. | Facile cyclometallation of a mesitylsilylene: synthesis and preliminary catalytic activity of iridium (III) and iridium (V) iridasilacyclopentenes | |
| Clegg et al. | X-ray crystal structure of bismuth dimethylamide | |
| Chanda et al. | Effect of 2-(2-Pyridyl) azole-Based Ancillary Ligands (L1-4) on the Electrophilicity of the Nitrosyl Function in [RuII (trpy)(L1-4)(NO)] 3+[trpy= 2, 2 ‘: 6 ‘, 2 ‘‘-Terpyridine]. Synthesis, Structures, and Spectroscopic, Electrochemical, and Kinetic Aspects | |
| Xu et al. | Four‐, five‐and six‐coordinated transition metal complexes based on naphthalimide Schiff base ligands: Synthesis, crystal structure and properties | |
| Beauchamp et al. | Synthesis and crystal structure of chlorobis (η5-cyclopentadienyl) purinato titanium (IV), a model compound for the interaction of the antitumor titanocene dichloride molecule with DNA bases | |
| CN1195766C (en) | Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same | |
| Užarević et al. | Mechanosensitive metal–ligand bonds in the design of new coordination compounds | |
| Richardson et al. | Benzotriazole as a structural component in chelating and bridging heterocyclic ligands; ruthenium, palladium, copper and silver complexes | |
| CN1067430A (en) | Preparation phosphino-hydrocarbon-group VIII-metal complexes and contain the anti-tumor compositions method of these complex compounds | |
| CN1816556A (en) | Method for producing tris-ortho-metallated complexes and use of such complexes in oleds | |
| CN101381380B (en) | Platinum (II) complexes and antineoplastic activity thereof | |
| CN1068573A (en) | Preparation phosphino-hydrocarbon-group VIII-metal complexes and contain the anti-tumor compositions method of these complex compounds | |
| CN1021912C (en) | Method for the preparation of platinum-(iv)-diamine composite | |
| Guo et al. | Synthesis and structural characterization of novel mixed-valent samarium and divalent ytterbium and europium complexes supported by amine bis (phenolate) ligands | |
| Prater et al. | A quadruply-bonded dirhenium complex bridged by two N1/N6 adenate ligands | |
| Ilango et al. | Samarium complexes of a σ-/π-pyrrolide/arene based macrocyclic ligand | |
| CN1578658A (en) | Metal organic antitumour agent | |
| CN112079853A (en) | Zinc complex with 2-pyridylaldehyde thiosemicarbazone as ligand and synthetic method and application thereof | |
| Grguric-Sipka et al. | Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin | |
| CN1016345B (en) | Process for preparing anti-tumour platinum complexes | |
| Yao et al. | Bis (2, 6-di-tert-butyl-4-methylphenolato-O)(η5-methylcyclopentadienyl)(tetrahydrofuran-O) ytterbium | |
| Yoo et al. | Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents | |
| CN109265488A (en) | Iridium anticancer complex and its preparation method and application containing two tooth cheland of phosphinimine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication |